Testing of APOL1 status is being used in niche clinical settings, including for evaluation of living kidney donors.20,21 To our knowledge, there are no proven interventions at this time, but there appears to be consensus that the presence of high-risk alleles alone does not necessarily lead to kidney failure. Here, APOL1 is linked to kidney failure.